HIGHLIGHTS
- who: . and colleagues from the Texas AandM University, United States have published the research work: Druggable targets and therapeutic development for COVID-19, in the Journal: (JOURNAL)
SUMMARY
In the past 2 decades, there have been three coronavirus outbreaks, severe acute respiratory syndrome (SARS) in 2003, Middle East respiratory syndrome (MERS) in 2012, and coronavirus disease 2019 (COVID-19) in 2019. For COVID-19, it was identified that the novel coronavirus SARS-CoV-2 was the causative pathogen. SARS-CoV-2, a new member of the genus Betacoronavirus, was most closely related to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.